|Best Practice || > About > Best Practice
Principles of transparency and best practice
Posted in July 7, 2018 and printed in February 20, 2019
Table of Contents
- The URL address of official journal web site is https://www.escienceediting.org/.
'Aims & Scope' statement: It aims to improve the culture and health of human being by promoting the quality of editing and publishing scientific, technical, and medical journals but, not limited to. Expected readers are editors, publishers, reviewers, and authors of the journals around the world; Its scope includes the follows:
Policy of journal editing
Data mining on the editing and publishing
Systematic review on medical journal publishing and editing
Research ethics and medical ethics including clinical registration, statement of human and
animal health protection, and conflict of interest
Publication ethics: fabrication, falsification, plagiarism, duplicate publication, and authorship
Crossref Similarity Check (CrossCheck)
Legal issue in journal publishing
Peer review process
Reporting guideline for medical journals
Medical and scientific literature databases
Advanced information technology applicable to journal editing and publishing including PubMed Central schema, journal article tag suite schema, Digital Object Identifier, Crossref Check for Updates (CrossMark), Funder Registry (FundRef), ORCID, datacite, QR code, and App
International standard of journal editing and publishing including International Committee of Medical Journal Editors’ Recommendations
Reference styles including Vancouver (NLM) style, APA style, IEEE style, and ACS style Digital publishing in the web and App
Education and training of editors, reviewers, and authors
Bibliometrics and scientometrics
Finance of journal publishing
History of scholarly journal
Copyright and Creative Commons License
Open access and public access approaches
Readership: It is primarily for scientific journal editors and personnels who works for scientific journals. Its readership can be expanded to other positions: • Researchers on journal publishing and bibliometrics can get the recent topics of journal publishing and editing; • Professors on communication can access and adopt a variety of data for education; • Students can understand the recent trends of the journal publishing and editing; • Policy makers are able to reflect the results of the articles to the nation-wide science promotion policies; • The scientists are able to read the advancement in the journal to be submitted so that they have a better knowledge on the journal selection.
Authorship criteria: https://www.escienceediting.org/authors/authors.php Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author and first author: Science Editing does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. Science Editing does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors. Correction of authorship after publication: Science Editing does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
Duplicate submission and redundant publication
https://www.escienceediting.org/authors/authors.php#32: Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Submitted manuscripts are screened for possible plagiarism or duplicate publication by CrossCheck upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.
pISSN: 2288-7474 eISSN; 2588-8063
2. Name of journal
The official journal title is Science Editing. Abbreviated title is Sci Ed.
Science Editing reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria, it is dispatched to three investigators in the field with relevant knowledge. Assuming the manuscript is sent to reviewers, Science Editing waits to receive opinions from at least two reviewers. In addition, if deemed necessary, a review of statistics may be requested. The authors’ names and affiliations are removed during peer review. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers. An initial decision will normally be made within 4 weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance/rejection for publication is forwarded to the corresponding author from the editor. All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the decision process. Editors will not handle their own manuscripts although they are commissioned ones.We neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts. Commissioned manuscripts also reviewed before publication. We adopts double-blind peer review in which case, not only authors but also reviewers do not know each other.
4. Ownership and management
Information about the ownership: This journal is owned by the publisher, the Korean Council of Science Editors https://www.kcse.org/.
Management team of a journal
- Journal management team (2020~2022)
- Journal Manager: Kihong Kim, Ajou University, Korea
- Manager of the Review Process: Jung A Kim, Hanyang University, Korea
- Ethics Editor: Cheol-Heui Yun, Seoul National University, Korea
- Statistics Editor: Yong Gyu Park, The Catholic University of Korea, Korea
- Manuscript Editor: Jae Hwa Chang, Infolumi, Korea
- Layout Editor: Da Hye Lee, Academya, Korea
- Website and JATS XML File Producers: Minyoung Choi M2community, Korea; Jeonghee Im, M2community, Korea
- Administrative Manager: Jisoo Yoon, Korean Council of Science Editors, Korea
5. Governing body
The governing body is the journal's editorial board.
6. Editorial team and contact information
Editorial team is available from Editorial Board page at the front part of the journal.
Administrative Manager: Jisoo Yoon
22 Teheran-ro 7-gil, Gangnam-gu, Seoul 06130, Korea
Copyright policy: All published papers become the permanent property of the Korean Council of Science Editors. Copyrights of all published materials are owned by the Korean Council of Science Editors. Permission must be obtained from the Korean Council of Science Editors for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
Licensing information: This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).
Deposit policy: According to the deposit policy (self-archiving policy) of Sherpa/Romeo(http://www.sherpa.ac.uk/), authors cannot archive pre-print (i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.
Neither page charge, article processing fee nor submission fee will be applied. It is the platinum open access journal.
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
10. Publication Ethics
Journal policies on authorship and contributorship
https://www.escienceediting.org/authors/ethics.php ; Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author and first author: Science Editing does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. Science Editing does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors.
Correction of authorship after publication: Science Editing does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
How the journal will handle complaints and appeals;
The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from:
Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform the cases, they can send a letter to editor For the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
Who is responsible to resolve and handle complaints and appeals?
The Editor, Editorial Board, or Editorial Office is responsible for them.
What may be the consequence of remedy?
It depends on the type or degree of misconduct. The consequence of resolution will follow the guidelines of the Committee of Publication Ethics (COPE).
Journal policies on conflicts of interest / competing interests
https://www.escienceediting.org/authors/ethics.php; The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
Journal policies on data sharing and reproducibility;
Open data policy
For clarification on result accuracy and reproducibility of the results, raw data or analysis data will be deposited to a public repository, for example, Harvard Dataverse (https://dataverse.harvard.edu/dataverse/) after acceptance of the manuscript. Therefore, submission of the raw data or analysis data is mandatory. If the data is already a public one, its URL site or sources should be disclosed. If data cannot be publicized, it can be negotiated with the editor. If there are any inquiries on depositing data, authors should contact the editorial office.
Clinical data sharing policy
This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.
Table 1. Examples of data sharing statements that fulfill these ICMJE requirements*
|Will individual participant data be available (including data dictionaries)?
|What data in particular will be shared?
||All individual participant data collected during the trial, after deidentification.
||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
|What other documents will be available?
||Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code
||Study protocol, statistical analysis plan, analytic code
|When will data be available (start and end dates)?
||Immediately following publication. No end date.
||Beginning at 3 months and ending at 5 years following the article publication.
||Beginning at 9 months and ending at 36 months following the article publication.
||Anyone who wishes to access the data.
||Researchers who provide a methodologically sound proposal.
||Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose.
|For what types of analyses?
||To achieve aims in the approved proposal.
||For individual participant data meta-analysis.
|By what mechanism will data be made available?
||Data are available indefinitely at (link to be included).
||Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement.
||Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata.
||Data are available for 5 years at a third-party website (link to be included).
||Information regarding submitting proposals and accessing data may be found at (link to be provided).
ICMJE = International Committee of Medical Journal Editors.
*These examples are meant to illustrate a range of, but not all, data sharing options.
Journal's policy on ethical oversight; When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
Journal's policy on intellectual property; All published papers become the permanent property of the Korean Council of Science Editors. Copyrights of all published materials are owned by the Korean Council of Science Editors.
Journal's options for post-publication discussions and corrections: The post-publication discussion is available through letter to editor. If any readers have a concern on any articles published, they can submit letter to editor on the articles. If there found any errors or mistakes in the article, it can be corrected through errata, corrigenda, or retraction.
It is to be published biannually. Supplement issues may be published.
This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Is is accessible without barrier from Korea Citation Index (https://kci.go.kr) or National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.
14. Revenue sources
Revenue sources of journal were from the support of publisher (the Korean Council of Science Editors), Korea Government’s support, and advertising rates.
Science Editing accepts advertisements on the following basis:
Eligibility of the advertised products or services
All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
- Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
- We reserves the right to decline or cancel any advertisement at any time.
- Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.
Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the editorial office. The acceptance of advertisement will be discussed by the editorial board and will be ultimately approved by the publisher.
For one print copy issue, the advertisement price for one whole page is USD 1,000 (or KRW 1,000,000). If the advertisement is half a page, the price is reduced by half. For a quarter of the page, this price is reduced by one quarter. For banner advertisements on the website, the price is negotiable according to the duration of its exposure on the journal homepage. The price is usually greater than that for print copies.
Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.
Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements, so readers must keep this in mind when reading or seeing advertisements.
16. Direct marketing
Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.